Tag: Survival improvement in pediatric oncology

Home / Survival improvement in pediatric oncology

Categories

Eflornithine is approved by USFDA for adult and pediatric patients with high-risk neuroblastoma

The FDA approved eflornithine (IWILFIN, USWM, LLC) on December 13, 2023, to lower the risk of relapse in adults and children with high-risk neuroblastoma (HRNB) who had a partial response to previou...
survival-improvement-in-pediatric-oncology

We Are Online! Chat With Us!
Scan the code